Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

S. 1416, Affordable Prescriptions for Patients Act of 2019 (CBO Report for Congress)

Premium   Download PDF Now (2 pages)
Congress 116th
Date Requested June 28, 2019
Requested By the Senate Committee on the Judiciary
Date Sent July 19, 2019
Description:
The bill would Define “product hopping” in the Federal Trade Commission Act and establish a statutory framework for the Federal Trade Commission’s (FTC’s) litigation authority against manufacturers that engage in such practices Allow FTC to impose civil penalties and seek other appropriate relief in district court from parties that violate antitrust law in this area Limit the number of patents that can be litigated under some provisions of the Biologics Price Competition and Innovation Act of 2009 Impose a private sector mandate by limiting the number of patents that may be asserted in infringement claims for a small number of biological products   Estimated budgetary effects would stem from Generic or biosimilar drugs entering the market earlier, on average, than would be the case under current law, resulting in lower federal spending for prescription drugs and subsidies for health insurance

« Return to search CBO reports